Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma Allogeneic hematopoietic stem cell ...
Among patients undergoing stem-cell transplantation from matched related donors, cyclophosphamide plus cyclosporin led to significantly longer GVHD-free, relapse-free survival than standard ...
Phase II clinical trial of S-1 and paclitaxel in combination followed by 5-fluorouracil/epirubicin/cyclophosphamide (FEC) as neoadjuvant treatment for HER2-negative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback